Cargando…
CXCR6-CXCL16 Axis Promotes Breast Cancer by Inducing Oncogenic Signaling
SIMPLE SUMMARY: Breast cancer (BrCa) is the second leading cause of cancer-related deaths in American women, and its incidence is on the rise. Insufficient understanding of the mechanisms leading to BrCa limits the effectiveness of the treatment. In this article, we show the importance of a chemokin...
Autores principales: | Mir, Hina, Kapur, Neeraj, Gales, Dominique N., Sharma, Praveen K., Oprea-Ilies, Gabriela, Johnson, Anita T., Singh, Rajesh, Singh, Shailesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306453/ https://www.ncbi.nlm.nih.gov/pubmed/34298782 http://dx.doi.org/10.3390/cancers13143568 |
Ejemplares similares
-
CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and α(v)β(3) integrin clustering
por: Singh, Rajesh, et al.
Publicado: (2016) -
Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation
por: Mir, Hina, et al.
Publicado: (2019) -
The interplay of pineal hormones and socioeconomic status leading to colorectal cancer disparity
por: Haynes, Talaijha, et al.
Publicado: (2022) -
Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways
por: Ward, Ashley B., et al.
Publicado: (2018) -
Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathways
por: Saunders, Ian T., et al.
Publicado: (2019)